ArticleAlimentary pharmacology & therapeutics2017

Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.

W T van Haaften et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.